Quality of life of patients suffering from chronic heart failure in Central Portugal

Authors

  • Luiz Miguel Santiago Faculdade de Medicina da Universidade de Coimbra Clínica Universitária de Medicina Geral e Familiar da Faculdade de Medicina da Universidade de Coimbra USF Topázio, ACES Baixo Mondego http://orcid.org/0000-0002-9343-2827
  • João Vitor Fernandes MD. Faculdade de Medicina da Universidade de Coimbra. Coimbra, Portugal. https://orcid.org/0000-0002-1964-2025
  • João Pestana MD, Médico Especialista em Medicina Geral e Familiar. USF Topázio, ACeS Baixo Mondego. Coimbra, Portugal.
  • Raul Garcia MD, Médico Especialista em Medicina Geral e Familiar. USF Fernando Namora, ACeS Baixo Mondego. Condeixa-a-Nova, Portugal. https://orcid.org/0000-0003-0572-2240

DOI:

https://doi.org/10.32385/rpmgf.v40i3.13711

Keywords:

Chronic heart failure, General practice, Quality of life

Abstract

Objectives: To evaluate chronic heart failure patient’s (PSCHF) quality of life (QoL) and to ascertain its relationship with context variables, comparing results between a generic and a specific QoL measurement tool.

Methods: Observational cross-sectional study, in a convenience sample of PSCHF in 2022, applying in self-fulfilment, with the investigator’s help if requested, the Euro Quality of Life Instrument – 5D (EQ5D-3l), the Kansas City Cardiomyopathy Questionnaire (KCCQ) and context variables in the General Practice/Family setting, in random days. Good or bad QoL according to the median value. EQ5D-3l was studied according to the Portuguese norm.

Results: A n=50 sample, n=29 (58%) women, mean age 74.1±8.9 years, was studied. Significant differences were found for the level of studies, inferior for women (p=0.019). For 40% of PSCHF, there was unfamiliarity of suffering from it. Spearman correlation, between the EQ-5D-3L score and the QoL-specific domain of KCCQ, was ρ=0.452, p=0.001, and between EQ-5D-3L score and the KCCQ Overall Summary Scale, ρ=0.556, p<0.001. For the arbitrary categories of the KCCQ Overall Summary Scale (p=0.189) and the EQ5D3l Portuguese norm (p=0.242), between genders, there was no difference, with females showing worse results.

Discussion: Instruments for measuring the therapeutic results and health consequences in PSCHF can change the actual paradigm of CHF treatment, QoL in PSCHF being one of those changes, and doctors becoming aware of PSCHF’s personal and social determinants.

Conclusion: Bad QoL was revealed for 70.0% of this sample and bad QoL for PSCHF for 50.0%, females with worse results.  EQ-5D is easier to apply in a consultation ambiance, with only five questions, with KCCQ being more specific for PSCHF.

Downloads

Download data is not yet available.

Author Biography

  • Luiz Miguel Santiago, Faculdade de Medicina da Universidade de Coimbra Clínica Universitária de Medicina Geral e Familiar da Faculdade de Medicina da Universidade de Coimbra USF Topázio, ACES Baixo Mondego

    Luiz Miguel de Mendonça Soares Santiago é Licenciado em Medicina pela Universidade de Coimbra desde 1979, Mestre em Saúde Pública pela Universidade de Coimbra desde 2006 e Doutorado por unanimidade com distinção e louvor, pela Universidade de Coimbra, na Especialidade de Sociologia Médica, ramo de Medicina Preventiva e Comunitária desde 11/11/2009.

    É desde1/7/2017 Professor Associado da Faculdade de Medicina da Universidade de Coimbra, regendo as Unidades Curriculares de MISP IV, 3º Ano e de Medicina Geral e Familiar, 5º Ano.

    Desde 30 de Janeiro de 2018 tem o título de "Agregado".

    Médico, especialista em Medicina Geral e Familiar, é Consultor com o Grau de Assistente Graduado Sénior da Carreira de Medicina Geral e Familiar desde 2002, sendo orientador no Internato Complementar de Medicina Geral e Familiar desde 2006, tendo exercido na Unidade de Saúde Familiar Topázio em Coimbra, onde ainda continua actividade clínica, agora reduzida.

    Professor Associado Convidado da Universidade da Beira Interior, onde é regente das cadeiras de CSP I, II e III entre 2011 e 2017.

    Desde 2014 até 2017 foi Professor Adjunto Convidado da Coimbra Health Scholl lecionando Patologia Geral.   

    Membro da Academia Europeia de Professores em Medicina Geral e Familiar (EURACT) é orientador de Teses de Mestrado Integrado e de Mestrado Pré-Bolonha bem como de Doutoramento, na Universidade de Coimbra (2) e na Universidade da Beira Interior (6).

    É membro da Comissão de Ética da ARS do Centro.

    Tem vasta bibliografia publicada individualmente e em co-autoria em revistas nacionais e internacionais com “revisores-par” e indexadas (27 artigos).

    Desde março de 2017 é membro investigador do CEISUC, FEUC.

    Em Novembro de 2017 é eleito sócio correspondente da Academia Nacional de Medicina.

    Aguarda a marcação de Provas de Agregação a serem prestadas na Universidade da Beira Interior.

References

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726.

Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2022;27(2):465-92.

Prazeres F, Santiago LM, Simões JA. Defining multimorbidity: from English to Portuguese using a Delphi technique. BioMed Res Int. 2015;2015:965025.

Ceia F, Fonseca C, Mota T, Morais H, Matias F, Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICCA study. Eur J Heart Fail. 2002;4(4):531-9.

Fonseca C, Brás D, Araújo I, Ceia F. Heart failure in numbers: estimates for the 21st century in Portugal. Rev Port Cardiol. 2018;37(2):97-104.

Nieminen MS, Dickstein K, Fonseca C, Serrano JM, Parissis J, Fedele F, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015;191:256-64.

Comín-Colet J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, Manzano L, et al. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Rev Esp Cardiol. 2016;69(3):256-71.

Johansson I, Joseph P, Balasubramanian K, McMurray JJ, Lund LH, Ezekowitz JA, et al. Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure Study of 23 000 patients from 40 countries. Circulation. 2021;143(22):2129-42.

Moradi M, Daneshi F, Behzadmehr R, Rafiemanesh H, Bouya S, Raeisi M. Quality of life of chronic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2020;25(6):993-1006.

van der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434-40.

Almeida CS. Qualidade de vida no doente com insuficiência cardíaca [dissertation]. Coimbra: Faculdade de Medicina da Universidade de Coimbra; 2018. Available from: https://hdl.handle.net/10316/82291

Ferreira PL, Ferreira LN, Pereira LN. Contributos para a validação da versão portuguesa do EQ-5D [Contribution for the validation of the Portuguese version of EQ-5D]. Acta Med Port. 2013;26(6):664-75. Portuguese

Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population norms. Qual Life Res. 2014;23(2):425-30.

Nave-Leal E, Pais-Ribeiro J, Oliveira MM, Silva N, Soares R, Fragata J, et al. Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure. Rev Port Cardiol. 2010;29(3):353-72.

Broeiro P. Literacia em saúde e utilização de serviços [Health literacy and use of health services]. Rev Port Med Geral Fam. 2017;33(1):6-8. Portuguese

Coelho A, Vilares C, Silva M, Rodrigues C, Costa M, Gordicho S, et al. Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito [Research on medication adherence in the Portuguese population: a scoping review]. Rev Port Med Geral Fam. 2017;33(4):262-76. Portuguese

Sousa S, Pires A, Conceição C, Nascimento T, Grenha A, Braz L. Polimedicação em doentes idosos: adesão à terapêutica [Polypharmacy in elderly patients: treatment adherence]. Rev Port Med Geral Fam. 2011;27(2):176-82. Portuguese

Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(20):2379-90.

Niklasson A, Maher J, Patil R, Sillén H, Chen J, Gwaltney C, et al. Living with heart failure: patient experiences and implications for physical activity and daily living. ESC Heart Fail. 2022;9(2):1206-15.

Ordem dos Médicos. Juramento de Hipócrates. Available from: https://ordemdosmedicos.pt/wp-content/uploads/2017/08/Juramento_de_Hip%C3%B3crates.pdf

Botelho F, Silva C, Cruz F. Epidemiologia explicada: viéses [Explained epidemiology: bias]. Acta Urol. 2010;27(3):47-52. Portuguese

Rice H, Say R, Betihavas V. The effect of nurse-led education on hospitalisation, readmission, quality of life and cost in adults with heart failure: a systematic review. Patient Educ Couns. 2018;101(3):363-74.

Coelho BM, Santiago LM. Medicina centrada na pessoa: validação populacional de um instrumento de medida pela pessoa [Person-centered medicine: validation of a person perception instrument]. Rev Port Med Geral Fam. 2022;38(3):247-56. Portuguese

Spertus JA, Jones PG. Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) [homepage]. Eprovide – Mapi Research Trust; 2015. Available from: https://eprovide.mapi-trust.org/instruments/kansas-city-cardiomyopathy-questionnaire-12

Published

2024-07-08

How to Cite

Quality of life of patients suffering from chronic heart failure in Central Portugal. (2024). Portuguese Journal of Family Medicine and General Practice, 40(3), 210-8. https://doi.org/10.32385/rpmgf.v40i3.13711

Most read articles by the same author(s)

1 2 3 4 5 6 > >>